Identification of novel CBFA1/RUNX2 mutations causing cleidocranial dysplasia

Area of Science:

• Genetics
• Molecular Biology
• Orthopedics

Background:

• Core binding factor A1 (CBFA1/RUNX2) is a critical transcription factor for osteoblast differentiation.
• Haploinsufficiency of CBFA1/RUNX2 causes cleidocranial dysplasia (CCD), a genetic disorder with characteristic skeletal and dental anomalies.

Purpose of the Study:

• To identify novel mutations in the CBFA1/RUNX2 gene in patients diagnosed with cleidocranial dysplasia.
• To investigate the genotype-phenotype correlation, particularly regarding clavicular dysplasia and bone density.

Main Methods:

• Polymerase Chain Reaction (PCR) and direct sequencing of leukocyte DNA from affected individuals and family members.
• Restriction fragment length polymorphism (RFLP) analysis using BsmI to confirm a specific missense mutation.

Main Results:

• Two novel CBFA1/RUNX2 mutations were identified: a missense mutation (R190W) in Family 1 and a frameshift deletion (C821del) in Family 2.
• Both mutations were absent in healthy family members, confirming their pathogenic role.
• Individuals with the R190W mutation exhibited more pronounced clavicular dysplasia, while both mutations were associated with reduced bone density, suggesting an increased risk for osteoporosis.

Conclusions:

• The study identified new genetic variants in CBFA1/RUNX2 associated with cleidocranial dysplasia.
• The findings highlight a potential link between CBFA1/RUNX2 mutations and reduced bone density, indicating an increased risk of osteoporosis in CCD patients.